https://pubmed.ncbi.nlm.nih.gov/24306002/
Effects of Bacille Calmette-Guerin after the first demyelinating event in the CNS
BCG, as compared to placebo, was associated with significantly reduced development of gadolinium-enhancing lesions in people with CIS for a 6-month period...
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0276423
Bacille Calmette Guerin (BCG) and prevention of types 1 and 2 diabetes: Results of two...
Background Diabetes is a common disease marked by high blood sugars. An earlier clinical trial in type 1 diabetic subjects (T1Ds) found that repeat BCG...